Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Cassandra Lanier

Plastic Surgery Austin, TX Physician Assistant

NPI 1447444245 CMS profile 5288319

2905 San Gabriel St Ste 100, Austin, TX 78705

Open in the dashboard

General payments

$37,880

119 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Cassandra Lanier of Austin, TX is reported in the CMS Open Payments database as having received $37,880 across 119 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $9,463 30
2024 General $6,540 28
2023 General $20,172 31
2022 General $628 12
2021 General $1,076 18

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Cassandra Lanier
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Cassandra Lanier were reported at $9,463. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Cassandra Lanier Plastic Surgery median Middle half National median
2019 $0 $371 $122–$1,483 $163
2020 $0 $158 $52–$438 $114
2021 $1,076 $249 $87–$752 $132
2022 $628 $274 $102–$793 $149
2023 $20,172 $299 $113–$891 $160
2024 $6,540 $361 $124–$1,062 $164
2025 $9,463 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Galderma Laboratories, L.P. $26,266 42 payments
  2. Revance Therapeutics, Inc. $8,691 12 payments
  3. AbbVie, Inc. $1,325 38 payments
  4. Allergan Inc. $556 17 payments
  5. Abbott Laboratories $420 3 payments
  6. Scpharmaceuticals Inc. $150 2 payments
  7. Amgen Inc. $125 1 payment
  8. Lilly USA, LLC $116 1 payment
  9. Corcept Therapeutics $104 1 payment
  10. Bayer HealthCare Pharmaceuticals Inc. $102 1 payment
  11. Other $26 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $32,501 15 payments
  2. Food and Beverage $4,988 91 payments
  3. Travel and Lodging $375 11 payments
  4. Education $17 2 payments
Products named General payments · program years 2021–2025
  1. DAXXIFY $8,672 11 payments
  2. BOTOX $964 28 payments
  3. FUROSCIX $150 2 payments
  4. PROCLAIM Neuromodulation $149 1 payment
  5. PROCLAIM Structural Heart $146 1 payment
  6. NATRELLE SALINE-FILLED BREAST IMPLANTS $142 1 payment
  7. FreeStyle Libre 2 $125 1 payment
  8. Otezla $125 1 payment
  9. ZEPBOUND $116 1 payment
  10. Korlym $104 1 payment
  11. Other $228 4 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

119 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record